期刊文献+

HIV-1 CRF07_BC毒株gp41 NHR结构域N51的表达及结构分析 被引量:2

Expression,structure and antigenicity analysis of N51 derived from the N-terminal heptad repeat domain in gp41 of HIV-1 CRF07_BC strain
暂未订购
导出
摘要 目的对来源于HIV-1中国流行株CRF07_BC的包膜糖蛋白gp41 NHR结构域的N51进行表达和结构及抗原性分析。方法运用重叠延伸PCR方法扩增出N51Fd基因,将其插入真核表达载体pFUSE-hIgG1-Fc2,并进行核苷酸序列测定。利用生物信息学软件、圆二色谱法、免疫印迹法对表达的N51FdFc-BC重组蛋白进行结构和抗原性分析。结果成功构建pFUSE/N51Fd-BC表达载体,并在真核表达体系实现了目的蛋白的高效表达。免疫印迹结果显示该重组蛋白大小约为35 000,可与抗HIV-1 gp41 N/C多肽的抗体反应。生物信息学分析显示N51FdFc-BC重组蛋白相对分子质量为34 315.1,等电点PI为7.59,且形成了无规则卷曲结构,易于与抗体反应,可作为抗原。圆二色谱的分析与生物信息学软件预测的结果一致。结论N51FdFc-BC重组蛋白具有无规则卷曲结构,可适合作为HIV-1亚单位疫苗的免疫原。 Objective To express N51 derived from the N-terminal heptad repeat (NHR) domain in gp41 of the HIV-1 CRF07_BC strain and analyze its molecular structure and antigenicity. Methods Overlapping PCR was used to amplify the DNA fragment encoding N51Fd gene, which was then subcloned into the vector pFUSE-hIgG1-Fc2. The construct was confirmed by DNA sequencing. The structure and antigenicity of the recombinant protein N51FdFc-BC were analyzed using bioinformatic software, circular dichroism, and Western blotting. Results A recombinant expression vector pFUSE/N51Fd-BC was successfully constructed. N51FdFc-BC recombinant protein with a relative molecular mass of about 35 000 was effectively expressed in mammalian 293T cells and could be recognized by rabbit antibodies against HW-1 gp41 N/C peptides as shown by Western blotting. Bioinformatic analysis showed that the recombinant protein N51FdFc-BC, with a relative molecular mass of 34 315.1 and a PI of 7.59, formed a secondary structure of random coil to allow its interactions as an antigen with antibodies. Circular dichroism measurement confirmed the random coil structure of N51FdFc-BC protein. Conclusion The recombinant protein N51FdFc-BC has a random coil structure and can be used as an immunogen for development of HIV-1 subunit vaccine.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第12期1737-1740,共4页 Journal of Southern Medical University
基金 国家自然科学基金-广东省联合基金重点项目(U0832001)~~
关键词 人免疫缺陷病毒1型 CRF07BC GP41 NHR结构域 N51基因 结构分析 human immunodeficiency virus type 1 CRF07_BC strain gp41 N-terminal heptad repeat domain N51 structure analysis
  • 相关文献

参考文献12

  • 1Harrison SC. Viral membrane fusion[J]. Nat Struct Mol Biol, 2008, 15(7): 690-8.
  • 2Karlsson Hedestam GB, Fouchier RA, Phogat S, et al. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus[J]. Nat Rev Microbiol, 2008, 6(2): 143-55.
  • 3Hoxie JA. Toward an antibody-based HIV-1 vaccine[J]. Annu Rev Med, 2010, 61: 135-52.
  • 4Bosch ML, Earl PL, Fargnoli K, et al. Identification of the fusion peptide of primate immunodeficiency viruses[J]. Science, 1989, 244 (4905): 694-7.
  • 5Gallaher WR. Detection of a fusion peptide sequence in the transmembrane protein of human immunodefieiency virus[J]. Cell, 1987, 50(3): 327-8.
  • 6Liu S, Wu S, Jiang S. HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds [J]. Curr Pharm Des, 2007. 13(2): 143-62.
  • 7Nelson JD, Kinkead H, Brunel FM, et al. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics[J]. Virology, 2008, 377(1): 170-83.
  • 8Miller MD, Geleziunas R, Bianchi E, et al. A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope[J]. Proc Natl Acad Sci USA, 2005, 102(41): 14759-64.
  • 9邵继平,姜世勃,刘叔文.基于gp41的HIV亚单位疫苗研究进展[J].细胞与分子免疫学杂志,2011,27(9):1047-1050. 被引量:6
  • 10Bianchi E, Joyce JG, Miller MD, et al. Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates[J]. Proc Natl Acad Sci USA, 2010, 107(23): 10655-60.

二级参考文献4

  • 1Zhang MY, Wang Y, Mankowski MK, et al. Cross-reactive HIV-1- neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the im- munogen [ J ]. Vaccine, 2009, 27 (6) : 857 - 863.
  • 2Correia BE, Ban YEA, Holmes MA, et al. Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope [ J ]. Structure, 2010, 18 ( 9 ) : 1116 - 1126.
  • 3Watson DS, Szoka FC, Jr. Role of hpid structure in the humoral im- mune response in mice to covalent lipid-peptides from the membrane proximal region of HW-1 gp41 [J]. Vaccine, 2009, 27(34) : 4672 - 4683.
  • 4Scherer EM, Zwick MB, Teyton L, et al. Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardio- lipin autoreactivity[ J]. AIDS, 2007, 21 (16): 2131 -2139.

共引文献5

同被引文献5

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部